MedPath

Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology

Active, not recruiting
Conditions
Squamous Cell Carcinoma of the Skin
Registration Number
NCT06327971
Lead Sponsor
Queen Mary University of London
Brief Summary

Evaluate a deep-learning model trained on computational histopathology for predicting outcomes in cutaneous squamous cell carcinoma

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Metastasis3 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Barts Health NHS Trust

🇬🇧

London, United Kingdom

Barts Health NHS Trust
🇬🇧London, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.